Exenatide 294 ezetimibe 295 famciclovir 296 famotidine 297 felodipine 298 fenofibrate 299. It is unknown whether this drug causes thyroid ccell tumors, including medullary thyroid carcinoma mtc, in humans, as the human relevance of exenatide extendedreleaseinduced rodent thyroid ccell. Variables examined included the drug route, dosing frequency, change in a1c%, weight change kg, hypoglycemia, adverse gi effects, and monthly drug cost. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection in the elderly based on renal function. General renal dosing guidelines agents not listed below click here for a specialized list of other renal medication dosing not listed in the alphabetical main section simple renal dosing guidelines. Pharmacokinetics and pharmacodynamics of exenatide. Design, synthesis and crystallization of a novel glucagon analog as a therapeutic agent. Although patients with severe renal impairment 10 to 30 mlminute have a 25% lower mean clearance than normal subjects crcl more than 80 mlminute, plasma quetiapine concentrations are still within the range of concentrations seen in normal subjects receiving the same dose. Exenatide pharmacokinetics in patients with mild to moderate renal dysfunction and end stage renal disease exenatide, an incretin mimetic exenatide, an incretin mimetic with antihyperglycemic actions, is under clinical investigation to treat type 2 diabetes.
Exenatide is a 39amino acid synthetic peptide amide with an empirical formula of c 184 h 282 n 50 o 60 s and a molecular weight of 4186. Mar 01, 2006 in the first group exenatide primed, patients were given doses of 0. Bydureon and bydureon bcise are both indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Exenatide immediaterelease byetta comes as a solution liquid in a prefilled dosing pen to inject subcutaneously under the skin. Some of these events occurred in patients experiencing nausea, vomiting, andor. Exenatide is twice daily, starting at 5 mcg within 60 minutes prior to a meal. General renal dosing for healthcare professionals guidelines. Tradjenta linagliptin dosing, indications, interactions. Bydureon exenatide extendedrelease for injectable suspension is a glp1 receptor agonist supplied as a sterile powder to be suspended in diluent and administered by subcutaneous injection. Drug dosing adjustments in patients with chronic kidney disease myrna y. The fifth edition of 2007 has been significantly expanded by dosage tables for children. The pharmacists will automatically adjust the doses of any of the antimicrobials included in the protocol according to the estimated creatinine clearance generally using the cockroftgault equation for patients.
Bydureon bcise exenatide extendedrelease injectable. The second group exenatide naive received placebo on a dosing schedule similar to that of the treatment group. The recommended dose of bydureon is 2 mg subcutaneously once every 7 days weekly. Initial period of release of surfacebound exenatide is followed by a gradual release from microspheres with peaks at week 2 and week 6 to 7 respectively. Aggrenox aspirinextendedrelease dipyridamole capsules. Drug dosing adjustments in patients with chronic kidney disease. Use with caution in patients with renal transplantationor moderate renal impairment 5. The fda emphasizes that exenatide should not be used in patients with severe renal impairment creatinine clearance renal disease, and it advises caution during. The objectives of these studies were to assess the. The dose can be administered at any time of day, with or without meals. They are available only as subcutaneous injections.
There have been postmarketing reports of altered renal function, including increased serum creatinine, renal impairment, worsened chronic renal failure and acute renal failure, sometimes. There have been reports of necrotising and haemorrhagic pancreatitis in people taking exenatide some of. Bennetts drug prescribing in renal failure has been the best pocket book for drug prescribing in patients with renal insufficiency and dialysis since the first edition in 1987. Analgesics antihypertensive and cardiovascular agents antimicrobial agents miscellaneous agents sedatives, hypnotics, and other drugs used in psychiatry. Increases insulin secretion and decreases glucagon secretion. However, no subjects had symptoms of hypoglycaemia. Pediatric drugs analgesics antihypertensive and cardiovascular agents antimicrobial agents miscellaneous agents sedatives, hypnotics, and other drugs used in psychiatry.
Postmarketing reports with exenatide, sometimes requiring hemodialysis and kidney transplantation. Abacavir abacavir lamivudine abacavir lamivudine zidovudine acarbose acebutolol acetaminophen acetazolamide acetohexamide acetohydroxamic acid acetylsalicylic acid aspirin acrivastine acyclovir adefovir adenosine albuterol inhaled albuterol oral alfentanil alfentanil allopurinol alprazolam alteplase tissuetype plasminogen activator. Data sources include ibm watson micromedex updated 10 apr 2020, cerner multum updated 6 apr 2020, wolters kluwer updated. Pharmacokinetics and pharmacodynamics of exenatide extended. Transient reductions in plasma glucose concentrations were observed for most subjects 0.
Sep 30, 2012 exenatide is a glucagonlike peptide1 receptor agonist, available in an immediaterelease ir, twicedaily formulation, which improves glycaemic control through enhancement of glucosedependent insulin secretion, suppression of inappropriately elevated postprandial glucagon secretion, slowing of gastric emptying and reduction of food intake. The day of weekly administration can be changed if necessary as long as the last dose was administered 3 or more days before the new day of administration. From april 2005 through october 2008, the agency received 62 reports of acute renal failure and 16 reports of renal insufficiency in individuals taking the drug. Renal dosage adjustment guidelines for antimicrobials the pharmacists will automatically adjust the doses of any of the antimicrobials included in the protocol according to the estimated creatinine clearance generally using the cockroftgault equation for patients. Exenatide pharmacokinetics in patients with mild to moderate.
Exenatideassociated ischemic renal failure diabetes care. Despite the benefits seen in using enoxaparin rather than ufh in treating vte, enoxaparins relatively high degree of renal excretion raises a concern for drug accumulation and a commensurate increased bleeding risk in patients with renal impairment. Byetta exenatide dosing, indications, interactions, adverse effects. Medscape type 2 diabetesspecific dosing for byetta exenatide. During clinical trials the safety and efficacy of exenatide were not different in geriatric patients versus younger adults. Bydureon exenatide dose, indications, adverse effects. If the oral route is not an option, weigh the benefits and potential risks when considering iv therapy. Munar, pharmd, bcps, and harleen singh, pharmd oregon state university college of pharmacy, portland, oregon. The effects of other variables that may influence drug dosing in renal disease, such as changes in urine ph and the role of drug transporters for secretion, are beyond the scope of this article. Renal dosage adjustment guidelines for antimicrobials.
Dosing guidelines book dosing guidelines for children dosing guidelines for adults. Exenatide immediaterelease solution is usually injected twice a day within 60 minutes before the. Exenatide is a glucagonlike peptide1 receptor agonist, available in an immediaterelease ir, twicedaily formulation, which improves glycaemic control through enhancement of glucosedependent insulin secretion, suppression of inappropriately elevated postprandial glucagon secretion, slowing of gastric emptying and reduction of food intake. If used in renal transplant patients, monitor for hypovolemia. Exenatide extendedrelease longacting bydureon comes as a powder to be mixed with liquid in a vial or a prefilled dosing pen to inject subcutaneously. Drug dosing adjustments in patients with chronic kidney. Seroquel quetiapine fumarate dose, indications, adverse.
Monitor glucose levelscarry candy with you in case of hypoglycemia. Dosing guidelines book school of medicine university of. Compared to glp1, exenatide has a longer halflife of 2. After one month, the dose may be increased to 10 mcg twice daily. In patients with endstage renal disease receiving dialysis, single doses of byetta 5 mcg were not well tolerated due to gastrointestinal side effects. Further information can be found in clinical pharmacology textbooks such as begg, 4 goodman and gilman, and cervelli 14 or the primary literature. The renal drug handbook the st georges hospital, adult critical. Data sources include ibm watson micromedex updated 10 apr 2020, cerner multum updated 6 apr 2020. Exenatide reference guide for safe and effective use from the american. They are sometimes referred to as glp1 receptor agonists. Dec 06, 20 the clinical effects of weekly exenatide were compared with those of twice daily dosing of exenatide byetta utilizing clinical data from the duration trials. Exenatide is fdaindicated to improve glycemic control in adult patients with type 2. Byetta exenatide dose, indications, adverse effects, interactions. Effect of renal impairment on the pharmacokinetics of exenatide.
Not recommended if severe renal impairment or endstage renal disease. Byetta exenatide dosing, indications, interactions. Exenatide pharmacokinetics in patients with mild to. Store in fridge if unused and at room temp if used. These pharmacokinetic properties led to an fdaapproved twotiered dosing strategy with a. Exenatide american journal of healthsystem pharmacy. Exenatide is a 39 amino acid peptide and synthetic version of exendin4, a hormone found in the saliva of the venomous lizard gila monster, with insulin secretagogue and antihyperglycemic activity. Exenatide is administered subcutaneously and mimics human glucagonlike peptide1 glp1. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Use caution when initiating or escalating exenatide regularrelease injection in patients with moderate renal impairment crcl 30 to 50 mlminute or egfr 30 to 50 mlminute1.
The authors make no claims of the accuracy of the information contained herein. The us food and drug administration fda is warning physicians that it has received reports of acute renal failure or renal insufficiency in 78 individuals who were treated with exenatide for. Use is not recommended in patients with a crcl exenatide or exenatide er or endstage renal disease esrd. Exenatide and kidney function nephrology jama jama network. Byetta exenatide dosing, indications, interactions, adverse. This book is distributed under the terms of the creative commons. They are not considered firstchoice drugs, but instead are typically used in combination with other drugs, in conjuction with diet and exercise. The information on dosage adjustments in renal impairment given in this book is based on cockcroftgault creatinine clearance and not egfr, since the majority. A catalogue record for this book is available from the british library. Exenatide is administered subcutaneously and mimics human glucagon like peptide1 glp1. Not recommended as firstline therapy for patients inadequately controlled on diet and exercise. Hence, it is important to explore the effects of renal impairment ri on novel antidiabetic medications such as exenatide.
1382 986 863 582 866 203 911 454 1099 450 1152 21 267 79 412 1410 8 1473 879 403 223 1167 31 1103 1093 1118 318 16 404 350 1085 1092 27 1280 1277